ALKEM LABORATORIES LTD SCREENER.

IN

Narration Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Trailing Best Case Worst Case
Sales 3,113.43 3,674.36 4,904.61 5,687.53 6,401.17 7,357.19 8,344.36 8,865.01 10,634.19 11,599.26 12,634.36 12,945.22 12,745.85
Expenses 2,700.36 3,247.60 4,038.37 4,686.56 5,392.25 6,236.87 6,868.47 6,919.66 8,579.84 9,977.45 10,437.60 10,605.18 10,590.81
Operating Profit 413.07 426.76 866.24 1,000.97 1,008.92 1,120.32 1,475.89 1,945.35 2,054.35 1,621.81 2,196.76 2,340.04 2,155.04
Other Income 162.25 176.11 226.72 109.99 115.42 82.15 101.72 230.25 146.26 100.74 79.39 - -
Depreciation 52.26 70.94 93.31 101.17 143.03 193.18 252.76 274.58 303.96 310.42 294.19 294.19 294.19
Interest 93.08 81.11 71.24 45.16 55.33 54.63 65.06 58.92 52.37 107.36 114.51 114.51 114.51
Profit before tax 429.98 450.82 928.41 964.63 925.98 954.66 1,259.79 1,842.10 1,844.28 1,304.77 1,867.45 1,931.34 1,746.34
Tax -5.36 59.23 176.18 59.96 287.56 181.02 110.48 224.33 163.96 297.96 292.79 16% 16%
Net profit 435.34 391.59 741.59 892.03 630.94 760.51 1,127.07 1,585.02 1,645.62 984.17 1,573.19 1,628.53 1,472.54
EPS 362.78 32.74 62.01 74.58 52.75 63.59 94.24 132.53 137.59 82.29 131.58 136.20 123.16
Price to earning 21.88 29.56 37.69 27.53 24.68 20.90 26.31 41.27 40.55 40.55 30.04
Price - - 1,356.45 2,204.90 1,988.35 1,750.85 2,325.85 2,769.80 3,620.70 3,396.10 5,335.25 5,522.94 3,699.91

RATIOS:
Dividend Payout 5.49% 12.21% 20.47% 20.10% 24.63% 25.15% 26.52% 22.63% 24.70% 60.74%
OPM 13.27% 11.61% 17.66% 17.60% 15.76% 15.23% 17.69% 21.94% 19.32% 13.98% 17.39%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 15.74% 13.08% 12.62% 11.60% 9.08% 11.60% 9.08%
OPM 16.91% 17.37% 17.56% 18.08% 17.39% 18.08% 16.91%
Price to Earning 30.04 31.06 30.21 32.26 40.55 40.55 30.04
ALKEM LABORATORIES LTD SCREENER.IN

Narration Sep-21 Dec-21 Mar-22 Jun-22 Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23
Sales 2,799.99 2,618.98 2,483.86 2,576.38 3,079.37 3,040.91 2,902.60 2,967.72 3,440.17 3,323.87
Expenses 2,175.61 2,120.53 2,146.63 2,373.14 2,625.46 2,441.86 2,549.35 2,578.53 2,693.44 2,616.28
Operating Profit 624.38 498.45 337.23 203.24 453.91 599.05 353.25 389.19 746.73 707.59
Other Income 41.96 53.52 5.56 51.41 50.67 45.33 -34.31 65.84 5.53 42.33
Depreciation 72.83 77.46 83.14 76.26 77.40 78.44 78.32 72.41 73.90 69.56
Interest 11.97 10.57 16.97 26.50 24.85 27.05 28.96 29.77 30.32 25.46
Profit before tax 581.54 463.94 242.68 151.89 402.33 538.89 211.66 352.85 648.04 654.90
Tax 23.01 -69.41 134.47 20.44 54.61 78.93 143.98 65.04 33.15 50.62
Net profit 544.26 525.66 107.58 127.64 330.84 454.71 70.98 286.73 620.52 594.96

OPM 22% 19% 14% 8% 15% 20% 12% 13% 22% 21%
ALKEM LABORATORIES LTD SCREENER.IN

Narration Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23
Equity Share Capital 11.96 23.91 23.91 23.91 23.91 23.91 23.91 23.91 23.91 23.91
Reserves 2,567.39 2,975.14 3,668.05 4,443.73 4,839.86 5,415.43 6,136.76 7,352.82 8,613.99 9,021.38
Borrowings 1,128.43 1,305.92 657.50 659.46 997.56 944.07 1,615.52 1,791.98 2,668.19 1,396.68
Other Liabilities 603.70 986.31 1,184.19 1,440.48 1,802.63 1,824.48 2,169.35 2,350.55 2,763.10 3,314.68
Total 4,311.48 5,291.28 5,533.65 6,567.58 7,663.96 8,207.89 9,945.54 11,519.26 14,069.19 13,756.65

Net Block 1,170.01 1,374.34 1,449.54 1,797.04 2,283.59 2,530.44 2,908.01 2,792.98 2,901.73 2,682.83
Capital Work in Progress - 110.69 172.42 299.26 380.97 492.96 362.97 393.28 339.48 323.24
Investments 588.01 480.78 508.57 553.00 444.27 323.62 261.39 332.78 370.98 621.82
Other Assets 2,553.46 3,325.47 3,403.12 3,918.28 4,555.13 4,860.87 6,413.17 8,000.22 10,457.00 10,128.76
Total 4,311.48 5,291.28 5,533.65 6,567.58 7,663.96 8,207.89 9,945.54 11,519.26 14,069.19 13,756.65

Working Capital 1,949.76 2,339.16 2,218.93 2,477.80 2,752.50 3,036.39 4,243.82 5,649.67 7,693.90 6,814.08
Debtors 366.93 527.08 567.51 713.64 1,080.50 1,248.41 1,649.36 1,607.21 1,884.60 2,132.18
Inventory 620.33 784.23 909.37 1,206.00 1,442.19 1,499.87 1,818.82 2,312.44 3,005.53 2,607.53

Debtor Days 43.02 52.36 42.23 45.80 61.61 61.94 72.15 66.17 64.69 67.09
Inventory Turnover 5.02 4.69 5.39 4.72 4.44 4.91 4.59 3.83 3.54 4.45

Return on Equity 17% 13% 20% 20% 13% 14% 18% 21% 19% 11%
Return on Capital Emp 13% 23% 21% 18% 16% 19% 22% 19% 13%
ALKEM LABORATORIES LTD SCREENER.IN

Narration Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23
Cash from Operating Activity 290.01 325.45 725.84 471.13 266.04 779.65 585.08 1,264.90 1,111.02 1,682.50
Cash from Investing Activity 353.45 -234.91 204.74 -293.67 -350.52 -318.37 -737.34 -994.87 -1,432.63 119.94
Cash from Financing Activity -599.95 -51.78 -927.27 -137.88 84.56 -378.94 79.15 -271.75 379.57 -1,760.82
Net Cash Flow 43.51 38.76 3.31 39.58 0.08 82.34 -73.11 -1.72 57.96 41.62
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: support@screener.in
s… do ANYTHING.
COMPANY NAME ALKEM LABORATORIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 11.96
Face Value 2.00
Current Price 5,335.25
Market Capitalization 63,790.93

PROFIT & LOSS

Report Date Mar-14 Mar-15 Mar-16 Mar-17
Sales 3,113.43 3,674.36 4,904.61 5,687.53
Raw Material Cost 1,435.90 1,724.28 2,068.32 2,511.13
Change in Inventory 50.21 33.68 104.44 289.60
Power and Fuel 60.33 53.31 66.33 86.34
Other Mfr. Exp 88.04 75.16 130.66 187.78
Employee Cost 531.56 645.87 874.08 1,018.25
Selling and admin 559.82 702.47 866.56 1,000.46
Other Expenses 74.92 80.19 136.86 172.20
Other Income 162.25 176.11 226.72 109.99
Depreciation 52.26 70.94 93.31 101.17
Interest 93.08 81.11 71.24 45.16
Profit before tax 429.98 450.82 928.41 964.63
Tax -5.36 59.23 176.18 59.96
Net profit 435.34 391.59 741.59 892.03
Dividend Amount 23.92 47.82 151.83 179.32

Quarters
Report Date Sep-21 Dec-21 Mar-22 Jun-22
Sales 2,799.99 2,618.98 2,483.86 2,576.38
Expenses 2,175.61 2,120.53 2,146.63 2,373.14
Other Income 41.96 53.52 5.56 51.41
Depreciation 72.83 77.46 83.14 76.26
Interest 11.97 10.57 16.97 26.50
Profit before tax 581.54 463.94 242.68 151.89
Tax 23.01 -69.41 134.47 20.44
Net profit 544.26 525.66 107.58 127.64
Operating Profit 624.38 498.45 337.23 203.24

BALANCE SHEET
Report Date Mar-14 Mar-15 Mar-16 Mar-17
Equity Share Capital 11.96 23.91 23.91 23.91
Reserves 2,567.39 2,975.14 3,668.05 4,443.73
Borrowings 1,128.43 1,305.92 657.50 659.46
Other Liabilities 603.70 986.31 1,184.19 1,440.48
Total 4,311.48 5,291.28 5,533.65 6,567.58
Net Block 1,170.01 1,374.34 1,449.54 1,797.04
Capital Work in Progress 110.69 172.42 299.26
Investments 588.01 480.78 508.57 553.00
Other Assets 2,553.46 3,325.47 3,403.12 3,918.28
Total 4,311.48 5,291.28 5,533.65 6,567.58
Receivables 366.93 527.08 567.51 713.64
Inventory 620.33 784.23 909.37 1,206.00
Cash & Bank 206.29 790.76 780.90 399.26
No. of Equity Shares 11,956,500.00 ### ### ###
New Bonus Shares
Face value 10.00 2.00 2.00 2.00

CASH FLOW:
Report Date Mar-14 Mar-15 Mar-16 Mar-17
Cash from Operating Activity 290.01 325.45 725.84 471.13
Cash from Investing Activity 353.45 -234.91 204.74 -293.67
Cash from Financing Activity -599.95 -51.78 -927.27 -137.88
Net Cash Flow 43.51 38.76 3.31 39.58

PRICE: 1,356.45 2,204.90

DERIVED:
Adjusted Equity Shares in Cr 1.20 11.96 11.96 11.96
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23

6,401.17 7,357.19 8,344.36 8,865.01 10,634.19 11,599.26
2,477.74 2,941.33 3,574.89 3,832.30 4,715.77 4,444.47
94.99 -3.64 229.95 333.84 535.48 -462.37
112.64 121.48 130.14 129.95 162.96 163.94
353.16 347.60 297.76 302.49 357.26 349.24
1,206.10 1,376.73 1,511.13 1,622.11 1,963.79 2,132.65
1,161.15 1,274.17 1,406.76 1,223.50 1,721.12 2,162.41
176.45 171.92 177.74 143.15 194.42 262.37
115.42 82.15 101.72 230.25 146.26 100.74
143.03 193.18 252.76 274.58 303.96 310.42
55.33 54.63 65.06 58.92 52.37 107.36
925.98 954.66 1,259.79 1,842.10 1,844.28 1,304.77
287.56 181.02 110.48 224.33 163.96 297.96
630.94 760.51 1,127.07 1,585.02 1,645.62 984.17
155.42 191.28 298.88 358.65 406.47 597.75

Sep-22 Dec-22 Mar-23 Jun-23 Sep-23 Dec-23

3,079.37 3,040.91 2,902.60 2,967.72 3,440.17 3,323.87
2,625.46 2,441.86 2,549.35 2,578.53 2,693.44 2,616.28
50.67 45.33 -34.31 65.84 5.53 42.33
77.40 78.44 78.32 72.41 73.90 69.56
24.85 27.05 28.96 29.77 30.32 25.46
402.33 538.89 211.66 352.85 648.04 654.90
54.61 78.93 143.98 65.04 33.15 50.62
 330.84 454.71 70.98 286.73 620.52 594.96
453.91 599.05 353.25 389.19 746.73 707.59

Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23

23.91 23.91 23.91 23.91 23.91 23.91
4,839.86 5,415.43 6,136.76 7,352.82 8,613.99 9,021.38
997.56 944.07 1,615.52 1,791.98 2,668.19 1,396.68
1,802.63 1,824.48 2,169.35 2,350.55 2,763.10 3,314.68
7,663.96 8,207.89 9,945.54 11,519.26 14,069.19 13,756.65
2,283.59 2,530.44 2,908.01 2,792.98 2,901.73 2,682.83
380.97 492.96 362.97 393.28 339.48 323.24
444.27 323.62 261.39 332.78 370.98 621.82
4,555.13 4,860.87 6,413.17 8,000.22 10,457.00 10,128.76
7,663.96 8,207.89 9,945.54 11,519.26 14,069.19 13,756.65
1,080.50 1,248.41 1,649.36 1,607.21 1,884.60 2,132.18
1,442.19 1,499.87 1,818.82 2,312.44 3,005.53 2,607.53
576.78 661.60 1,092.21 1,990.45 2,578.58 2,616.89
### ### ### ### ### ###

2.00 2.00 2.00 2.00 2.00 2.00

Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23

266.04 779.65 585.08 1,264.90 1,111.02 1,682.50
-350.52 -318.37 -737.34 -994.87 -1,432.63 119.94
84.56 -378.94 79.15 -271.75 379.57 -1,760.82
0.08 82.34 -73.11 -1.72 57.96 41.62

1,988.35 1,750.85 2,325.85 2,769.80 3,620.70 3,396.10

11.96 11.96 11.96 11.96 11.96 11.96